This clinical trial studies the effect of a quality of life intervention on decision-making in patients with early-stage lung cancer who are undergoing standard of care surgery or stereotactic body radiation therapy (SBRT). Providing quality of life outcome data to patients deciding between surgery and SBRT may help decrease decision regret and increase patient satisfaction with their care.
Age >= 18 years
Radiographic stage I-II non-small cell lung cancer (NSCLC)
Of note, separate tumor nodule(s) in an ipsilateral lobe different from that of the primary is considered T4 disease. However, these are treated as separate stage I or II lesions and will be eligible for this study.
Eligible for both surgery and SBRT
Radiographic stage III-IV NSCLC except as noted above
Eligible for either only surgery or SBRT, but not both
Eligible for palliative-intent treatments or supportive care only.
Pregnant female participants.
Parallel
Best Practice
Other interventionReceive usual care
Informational Intervention
Other interventionReceive QOL fact sheet
Questionnaire Administration
Other interventionAncillary studies
Decision regret
Compare the extent of decision regret based on Decision Regret Scale between the provision of quality of life (QOL) information versus usual care for standard of care surgery or stereotactic body radiation therapy (SBRT) treatment. The five-point decision regret score will be converted to a 100-point score as described by others, where a higher score reflects an increased decision regret. In this schema, a decision regret score \> 25 % is deemed moderate to severe regret. The dichotomized decision regret will be modeled as a function of group, time, and their interaction using a generalized estimating equations (GEE) logistic regression model with an autoregressive covariance structure. The rates of less than moderate to severe regret will be compared between groups at 6-months using a one-sided test about the appropriate contrast of model estimates.
Quality of Life (EORTC QLQ-C30)
Will compare QOL measures based on the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30) between the provision of QOL information versus usual care for standard of care surgery or SBRT treatment.
Quality of Life (QOL)
Will compare QOL measures based on the lung cancer- specific questionnaire (EORTC QLQ-LC13) between the provision of QOL information versus usual care for standard of care surgery or SBRT treatment.
Difference in consideration of regret
Compare decisions about treatment for early stage lung cancer and examined whether regret is a consideration in treatment decisions between those who received the quality of life fact sheet and those who did not.
Click on the lead sponsor to view all of their trials.
Roswell Park Cancer Institute
Lead sponsor
National Comprehensive Cancer Network
Collaborator
